Tags: double chin | shot | injection | fat

Double-Chin Shot Approved by FDA; Will It Become the New Botox?

By    |   Thursday, 30 April 2015 08:27 AM

The U.S. Food and Drug Administration has approved a new double-chin shot designed to destroy those pesky fat cells below the chin.

The body naturally produces deoxycholic acid, which helps absorb fat, and the new drug Kybella — or ATX-101 — acts as a synthetically derived form of the acid, The Washington Post reported.

Patients may receive as many as 50 injections in one treatment, with up to six treatments administered no less than a month apart, the newspaper noted. Kybella destroys fat cells and, if injected incorrectly, could destroy skin cells, the FDA warns.

The FDA's Dermatologic and Ophthalmic Drugs Advisory Committee voted unanimously to support the approval of the drug last month, according to a statement by Kythera Biopharmaceuticals, which produces the drug.

"For the first time, people have access to an FDA-approved, non-surgical treatment for submental fullness, a condition that can negatively impact the overall appearance of the face and can result in a person feeling older and heavier," Keith Leonard, president and CEO of Kythera, said in a company statement.

"With Kybella, physicians can offer a clinically-proven treatment that is customized to the patient and their treatment goals for an improved chin profile," he continued. "Importantly, Kybella treatment resulted in high patient satisfaction."

The Los Angeles Times reported that Kybella will be applied by physicians during office visits that run from 15 to 20 minutes. Kythera said many of its patients saw visible results after the initial two to four visits.

"In my dermatology practice, I see many patients who have undesirable fullness under the chin, even though they may have an otherwise balanced and harmonious facial appearance and be in great physical shape," Dr. Derek H. Jones, founder and medical director of Skin Care and Laser Physicians of Beverly Hills, said in a Kythera statement.

"I explain to my patients that submental fullness is often resistant to diet and exercise and could be a result of aging, genetics or weight gain. As an investigator in the clinical studies of Kybella, I’m excited about the opportunity to offer my patients a non-surgical option for reduction of submental fullness," he continued.

Related Stories:

© 2018 Newsmax. All rights reserved.

1Like our page
The U.S. Food and Drug Administration has approved a new double-chin shot designed to destroy those pesky fat cells below the chin.
double chin, shot, injection, fat
Thursday, 30 April 2015 08:27 AM
Newsmax Inc.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

America's News Page
© Newsmax Media, Inc.
All Rights Reserved